• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,267.34 -508.40
( -0.68%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
67,130.34 800.84
(1.21%)
Nikkei 225
10,313.41 -95.87
(-0.92%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
33.2
820.28
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.22
 

suraj ltd
Symphony surges after registering PAT of Rs 34 crore in Q3
Jan 29,2026

Revenue from operations remained flat at Rs 182 crore during the quarter.

Total operating expenditure for Q3 FY26 was Rs 151 crore, down 22.6% YoY. This was due to lower finished goods purchases (down 35.8% YoY) and lower other expenses (down 70.8% YoY).

The company posted a pre-tax profit of Rs 43 crore in Q3 FY26. It had recorded a pre-tax loss of Rs 7 crore in Q3 FY25.

Symphony, an Indian multi-national company with presence in over 60 countries is the world’s leading air cooler company. The company delivers market-leading products that comprise of design innovation, energy efficiency, distinctive styling, and customer-centricity.